Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

The aim of this study was to compare the time-to progression and overall survival (OS) in patients with metastatic breast cancer (MBC) with and without deleterious BRCA1/2 mutations. 195 women with MBC who were referred for BRCA genetic testing between 1997 and 2011 were included in the study. Logis...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bayraktar, S., Gutierrez-Barrera, A. M., Lin, H., Elsayegh, N., Tasbas, T., Litton, J. K., Ibrahim, N. K., Morrow, P. K., Green, M., Valero, V., Booser, D. J., Hortobagyi, G. N., Arun, B. K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3857726/
https://ncbi.nlm.nih.gov/pubmed/23370825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9567-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky